Overview
Ephedra is an alkaloid chemical compound traditionally obtained from the plant Ephedra sinica. The sale of ephedra-containing supplements intended to increase muscle weight or promote weight loss was banned in the United States in 2004 due to the risk for adverse effects and a lack of evidence for clinical effectiveness. The drug is still sold in Canada in OTC formulations for respiratory conditions associated with bronchial asthma.
Indication
Ephedra is indicated for the temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma. For the temporary relief of bronchial asthma in over-the-counter formulations.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
Wind-Cold & Cough Oral Liquid (Tong Xuan Li Fei) | 156181 | Medicine | A | 10/23/2008 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
FORMULA T.O. | abundance naturally ltd | 02239494 | Tablet - Oral | 8 MG | 5/1/2001 |
POUR IT ON THICK | kootenay born botanicals | 02232067 | Syrup - Oral | 1 X | 5/25/1998 |
THERMO 5000C CAPSULES | market america, inc. | 02229432 | Capsule - Oral | 125 MG / CAP | 12/18/1996 |
HERBAL COLD RELIEF CAP | jamieson laboratories ltd | 02094827 | Capsule - Oral | 312.5 MG / CAP | 12/31/1994 |
FLORASUN EPHEDRA CAP 250MG | laboratoire lalco inc. | 02052008 | Capsule - Oral | 250 MG / CAP | 12/31/1995 |
EPHEDRA VULGARIS-INJEEL FORTE LIQ (4D,10D,30D,200D/1.1ML) | 02055961 | Liquid - Oral | 4 D / 1.1 ML | 12/31/1993 | |
EPHEDRA VULGARIS-INJEEL LIQ (10D,30D,200D/1.1ML) | 02055988 | Liquid - Oral | 10 D / 1.1 ML | 12/31/1993 | |
DP FORMULA | pep products inc. | 02241790 | Tablet - Oral | 107 MG | 3/1/2000 |
DP FORMULA - 133MG TAB | pep products inc. | 02106302 | Tablet - Oral | 133 MG | 12/31/1994 |
EPHEDRA - CAP 300MG | nutrion health & fitness inc. | 02202042 | Capsule - Oral | 300 MG / CAP | 12/31/1996 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.